Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Scott, Andrew ^a   Powner, Michael B ^a   Gandhi, Pranita ^a   Clarkin, Claire ^b   Gutmann, David H ^c   Johnson, Randall S ^d   Ferrara, Napoleone ^e   Fruttiger, Marcus ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; DEVELOPMENTAL STABILITY; ENDOTHELIUM CELL; FUNCTIONAL MORPHOLOGY; GENE DELETION; GENE EXPRESSION; HYPEROXIA; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RADIAL ARTERY; RETINA BLOOD VESSEL; RETINA NERVE CELL; SMOOTH MUSCLE FIBER; ANIMAL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RETINA; TRANSGENIC MOUSE;

MUS;

ANIMALS; ASTROCYTES; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955619335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011863     Document Type: Article

References (51)

1. Alon T, Hemo I, Itin A, Pe'er J, Stone J, et al. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024-1028.
2. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, et al. (1999) Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126: 457-467.
3. Fruttiger M (2002) Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 43: 522-527.
4. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, et al. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15: 4738-4747.
5. Schnitzer J (1988) Astrocytes in the guinea pig, horse, and monkey retina: their occurrence coincides with the presence of blood vessels. Glia 1: 74-89.
6. Stone J, Dreher Z (1987) Relationship between astrocytes, ganglion cells and vasculature of the retina. J Comp Neurol 255: 35-49.
7. Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, et al. (1997) Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res 65: 555-568.
8. Provis JM, Sandercoe T, Hendrickson AE (2000) Astrocytes and blood vessels define the foveal rim during primate retinal development. Invest Ophthalmol Vis Sci 41: 2827-2836.
9. West H, Richardson WD, Fruttiger M (2005) Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 132: 1855-1862.
10. Chan-Ling T, Gock B, Stone J (1995) The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36: 1201-1214.
11. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, et al. (2001) Low IGF I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98: 5804-5808.
12. Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, et al. (1998) Identification of a human VPF/VEGF 39 untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9: 469-481.
13. Trollmann R, Gassmann M (2009) The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain. Brain Dev 31: 503-509.
14. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, et al. (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
15. Smith LE (2004) Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 14 Suppl A: S140-S144.
16. Ferrara N, Winer J, Burton T (1991) Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 5: 141-148.
17. Favard C, Moukadiri H, Dorey C, Praloran V, Plouet J (1991) Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell 73: 1-6.
18. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, et al. (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 39-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343.
19. Meeson AP, Argilla M, Ko K, Witte L, Lang RA (1999) VEGF deprivationinduced apoptosis is a component of programmed capillary regression. Development 126: 1407-1415.
20. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, et al. (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111.
21. Claxton S, Fruttiger M (2003) Role of arteries in oxygen induced vasoobliteration. Exp Eye Res 77: 305-311.
22. Engerman RL, Meyer RK (1965) Development of retinal vasculature in rats. Am J Ophthalmol 60: 628-641.
23. Claxton S, Fruttiger M (2005) Oxygen modifies artery differentiation and network morphogenesis in the retinal vasculature. Dev Dyn.
24. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, et al. (2003) Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 264: 275-288.
25. Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF- B and VEGF. Development 125: 1591-1598.
26. Gaengel K, Genove G, Armulik A, Betsholtz C (2009) Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29: 630-638.
27. Gu X, Samuel S, El Shabrawey M, Caldwell RB, Bartoli M, et al. (2002) Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 43: 496-502.
28. Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, et al. (1998) Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol 152: 1453-1462.
29. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, et al. (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72: 638-645.
30. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92: 905-909.
31. Bajenaru ML, Zhu Y, Hedrick NM, Donahoe J, Parada LF, et al. (2002) Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol 22: 5100-5113.
32. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71.
33. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, et al. (1999) VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159.
34. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, et al. (2003) VEGF164- mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198: 483-489.
35. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, et al. (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109: 327-336.
36. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, et al. (2000) Hypoxiainducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60: 4010-4015.
37. Chan-Ling T, Stone J (1992) Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci 33: 2148-2159.
38. Dorrell MI, Aguilar E, Jacobson R, Trauger SA, Friedlander J, et al. (2009) Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia.
39. Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL (2008) AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia 56: 1076-1090.
40. Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S (2006) Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J Clin Invest 116: 369-377.
41. Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, et al. (2006) Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206: 749-758.
42. Levy AP (1998) Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins. Trends Cardiovasc Med 8: 246-250.
43. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, et al. (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437: 417-421.
44. Diez-Roux G, Argilla M, Makarenkova H, Ko K, Lang RA (1999) Macrophages kill capillary cells in G1 phase of the cell cycle during programmed vascular regression. Development 126: 2141-2147.
45. Heidary G, Vanderveen D, Smith LE (2009) Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 24: 77-81.
46. Chen J, Connor KM, Aderman CM, Smith LE (2008) Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118: 526-533.
47. Lofqvist C, Chen J, Connor KM, Smith AC, Aderman CM, et al. (2007) IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A 104: 10589-10594.
48. Micieli JA, Surkont M, Smith AF (2009) A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity. Am J Ophthalmol 148: 536-543.
49. Zhang L, Conejo-Garcia JR, Yang N, Huang W, Mohamed-Hadley A, et al. (2002) Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. Biochem Biophys Res Commun 292: 860-868.
50. Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, et al. (2008) Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46: 74-80.
51. Magaud JP, Sargent I, Clarke PJ, Ffrench M, Rimokh R, et al. (1989) Double immunocytochemical labeling of cell and tissue samples with monoclonal antibromodeoxyuridine. J Histochem Cytochem 37: 1517-1527.